Policymakers in India are facing the dilemma between promoting the generic industry for social welfare and development of healthcare sector . In this context , how far will India’s new National Intellectual Property Rights (IPR) Policy be helpful in balancing IP rights with needs of the nations’s poor for cheaper medicines.